247 related articles for article (PubMed ID: 28147343)
21. Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma.
Korn P; Kampmann A; Spalthoff S; Jehn P; Tavassol F; Lentge F; Gellrich NC; Zimmerer R
Asian Pac J Cancer Prev; 2021 May; 22(5):1591-1597. PubMed ID: 34048190
[TBL] [Abstract][Full Text] [Related]
22. Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug Resistance.
Dahn ML; Cruickshank BM; Jackson AJ; Dean C; Holloway RW; Hall SR; Coyle KM; Maillet H; Waisman DM; Goralski KB; Giacomantonio CA; Weaver ICG; Marcato P
Mol Cancer Ther; 2020 May; 19(5):1110-1122. PubMed ID: 32156786
[TBL] [Abstract][Full Text] [Related]
23. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
Salah Z; Itzhaki E; Aqeilan RI
Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
[TBL] [Abstract][Full Text] [Related]
24. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.
Cho CY; Lee KT; Chen WC; Wang CY; Chang YS; Huang HL; Hsu HP; Yen MC; Lai MZ; Lai MD
Oncotarget; 2016 Mar; 7(12):14586-604. PubMed ID: 26910843
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content.
Morcelle C; Menoyo S; Morón-Duran FD; Tauler A; Kozma SC; Thomas G; Gentilella A
Cancer Res; 2019 Sep; 79(17):4348-4359. PubMed ID: 31292158
[TBL] [Abstract][Full Text] [Related]
26. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
[TBL] [Abstract][Full Text] [Related]
27. Functional role of RRS1 in breast cancer cell proliferation.
Song J; Ma Z; Hua Y; Xu J; Li N; Ju C; Hou L
J Cell Mol Med; 2018 Dec; 22(12):6304-6313. PubMed ID: 30320499
[TBL] [Abstract][Full Text] [Related]
28. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.
Turi Z; Senkyrikova M; Mistrik M; Bartek J; Moudry P
Cell Cycle; 2018; 17(1):92-101. PubMed ID: 29143558
[TBL] [Abstract][Full Text] [Related]
29. c-Src Phosphorylates and Inhibits the Function of the CIC Tumor Suppressor Protein.
Bunda S; Heir P; Li ASC; Mamatjan Y; Zadeh G; Aldape K
Mol Cancer Res; 2020 May; 18(5):774-786. PubMed ID: 32029440
[TBL] [Abstract][Full Text] [Related]
30. 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint.
Donati G; Peddigari S; Mercer CA; Thomas G
Cell Rep; 2013 Jul; 4(1):87-98. PubMed ID: 23831031
[TBL] [Abstract][Full Text] [Related]
31. iPSC-Derived Hereditary Breast Cancer Model Reveals the
Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
[TBL] [Abstract][Full Text] [Related]
32. Role of ribosomal protein mutations in tumor development (Review).
Goudarzi KM; Lindström MS
Int J Oncol; 2016 Apr; 48(4):1313-24. PubMed ID: 26892688
[TBL] [Abstract][Full Text] [Related]
33. Regulation of globin-heme balance in Diamond-Blackfan anemia by HSP70/GATA1.
Rio S; Gastou M; Karboul N; Derman R; Suriyun T; Manceau H; Leblanc T; El Benna J; Schmitt C; Azouzi S; Larghéro J; Karim Z; Macias-Garcia A; Chen JJ; Hermine O; Courtois G; Puy H; Gouya L; Mohandas N; Da Costa L
Blood; 2019 Mar; 133(12):1358-1370. PubMed ID: 30700418
[TBL] [Abstract][Full Text] [Related]
34. Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma.
Cui J; Zhang Q; Song Q; Wang H; Dmitriev P; Sun MY; Cao X; Wang Y; Guo L; Indig IH; Rosenblum JS; Ji C; Cao D; Yang K; Gilbert MR; Yao Y; Zhuang Z
Neuro Oncol; 2019 Nov; 21(11):1436-1446. PubMed ID: 31276594
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44.
Yeh M; Wang YY; Yoo JY; Oh C; Otani Y; Kang JM; Park ES; Kim E; Chung S; Jeon YJ; Calin GA; Kaur B; Zhao Z; Lee TJ
Sci Rep; 2021 Apr; 11(1):9219. PubMed ID: 33911148
[TBL] [Abstract][Full Text] [Related]
36. Ribosomal protein mutations in Korean patients with Diamond-Blackfan anemia.
Chae H; Park J; Lee S; Kim M; Kim Y; Lee JW; Chung NG; Cho B; Jeong DC; Kim J; Kim JR; Park G
Exp Mol Med; 2014 Mar; 46(3):e88. PubMed ID: 24675553
[TBL] [Abstract][Full Text] [Related]
37. Verification of EZH2 as a druggable target in metastatic uveal melanoma.
Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J
Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003
[TBL] [Abstract][Full Text] [Related]
38. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
39. Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1.
Chou CW; Wang CC; Wu CP; Lin YJ; Lee YC; Cheng YW; Hsieh CH
Neuro Oncol; 2012 Oct; 14(10):1227-38. PubMed ID: 22946104
[TBL] [Abstract][Full Text] [Related]
40. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
